Roche, Eli Lilly’s Alzheimer’s blood test gets U.S. FDA clearance

The U.S. Food and Drug Administration (FDA) has cleared Roche and partner Eli Lilly’s blood test to help identify signs of Alzheimer’s disease in people aged 55 and older with cognitive decline.